[ad_1]
1. Sanepar shares plummet after the regulatory agency’s decision on the rate adjustment
Sanepar shares opened the trading session on Wednesday with a strong devaluation after the Regulatory Agency for Delegated Public Services of Paraná (Agepar) decided to apply a rate adjustment of 5.11% as of February 5.
Around 10:53 am, the company drives sanitation Paraná fell 6.48% to 26.07 reais, while preferred shares lost 4.38% and ordinary shares, with less liquidity, fell 9.83%.
OR Ibovespa, on the other hand, operates at a high level. The index reached more than 120 thousand points for the first time to the maximum the day so far. At 11:13 a.m., it was up 0.2% to 119,651.91 points.
The readjustment had been suspended since September. At the end of August, Agepar had approved a 9.62% increase, which would begin in October.
In parallel to the new readjustment, the regulator defined that the process of opening the public consultation for the second periodic rate review will take place from January 4. The results of the preliminary studies indicate a basic rate of 5,3031 reais per m³, which corresponds to a reduction of 2.5882% in relation to the rate that will take effect in February.
2. The European Union seeks to rebalance ties with China with an investment agreement
A European Union It’s in China in accordance with an investment agreement that will give Business Greater access of Europeans to markets China and will help correct what the bloc sees as unbalanced economic ties.
European companies will be able to operate in China in sectors such as electric cars, private hospitals, real estate, advertising, the maritime industry, telecommunications cloud services, airline reservation systems and layover assistance. The agreement also includes commitments on climate change and labor rights.
3. UK approves AstraZeneca / Oxford vaccine against Covid-19
OR UK this Wednesday it became the first country in the world to approvera vaccine against coronavirus developed by the University of Oxford and to AstraZeneca.
The prime minister’s government Boris johnson, what has already ordered 100 million doses of the vaccine, said it accepted a recommendation from the Medicines and Health Products Regulatory Agency (MHRA) to grant an emergency authorization.
“The NHS (National Health Service) will be able to get these vaccines into people’s arms at the speed that they can be made,” Health Secretary Matt Hancock told Sky News.
Hancock said hundreds of thousands of doses will be available next week in the United Kingdom, which is already distributing a vaccine developed by the American. Pfizer and the German BioNTech.
Johnson called the approval a “triumph of British science.”
4. Anvisa receives authorization request for tests with Sputnik V vaccine
The National Sanitary Surveillance Agency (Anvisa) announced Tuesday night that received the authorization request for human trials on Phase 3 of the vaccine against COVID-19 The Russian Sputnik V in Brazil and is expected to respond within 72 hours, the regulatory agency said in a note.
The order of the tests was made by the União Química laboratory. Sputnik V, from the Russian Gamaleya institute, is already being applied in Russia and in other countries, like Argentina.
“Anvisa has held a series of meetings with the laboratory in recent weeks to guide and exchange information on the format of the study request and learn about the study proposal,” says the note from the regulator.
5. The public sector has a primary deficit of R $ 18.1 billion in November, says the Central Bank
The consolidated Brazilian public sector registered in November a primary deficit of R $ 18.1 billion, reported the central bank this Wednesday.
The central government gap (federal government, BC e Social Security) was 20.4 billion reais in the month, slightly above the gap of 18.2 billion reais registered in the same month of 2019.
Meanwhile, the states and municipalities had a surplus of 2.3 billion reais and the state companies, a deficit of 87 million reais.
Also considering expenses with interest, the country had a nominal deficit of R $ 20.1 billion in November.
In the accumulated in 12 months, the primary leak corresponds to 8.9% of the START.
